Drug resistance-related mutations T369V/I in the connection subdomain of HIV-1 reverse transcriptase severely impair viral fitness. 2017

Zheng Wang, and Junli Zhang, and Fan Li, and Xiaolin Ji, and Lingjie Liao, and Liying Ma, and Hui Xing, and Yi Feng, and Dan Li, and Yiming Shao
State Key Laboratory of Infectious Diseases Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of infectious Diseases, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Changping District, Beijing 102206, China; Division of Research of Virology and Immunology, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Changping District, Beijing 102206, China. Electronic address: wangzhengcdc@163.com.

Fitness is a key parameter in the measurement of transmission capacity of individual drug-resistant HIV. Drug-resistance related mutations (DRMs) T369V/I and A371V in the connection subdomain (CN) of reverse transcriptase (RT) occur at higher frequencies in the individuals experiencing antiretroviral therapy failure. Here, we evaluated the effects of T369V/I and A371V on viral fitness, in the presence or in the absence of thymidine analogue resistance-associated mutations (TAMs) and assessed the effect of potential RT structure-related mechanism on change in viral fitness. Mutations T369V/I, A371V, alone or in combination with TAMs were introduced into a modified HIV-1 infectious clone AT1 by site-directed mutagenesis. Then, experiments on mutant and wild-type virus AT2 were performed separately using a growth-competition assay, and then the relative fitness was calculated. Structural analysis of RT was conducted using Pymol software. Results showed that T369V/I severely impaired the relative virus fitness, and A371V compensated for the viral fitness reduction caused by TAMs. Structural modeling of RT suggests that T369V/I substitutions disrupt powerful hydrogen bonds formed by T369 and V365 in p51 and p66. This study indicates that the secondary DRMs within CN might efficiently damage viral fitness, and provides valuable information for clinical surveillance and prevention of HIV-1 strains carrying these DRMs.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond
D000072417 Protein Domains Discrete protein structural units that may fold independently of the rest of the protein and have their own functions. Peptide Domain,Protein Domain,Domain, Peptide,Domain, Protein,Domains, Peptide,Domains, Protein,Peptide Domains
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D016297 Mutagenesis, Site-Directed Genetically engineered MUTAGENESIS at a specific site in the DNA molecule that introduces a base substitution, or an insertion or deletion. Mutagenesis, Oligonucleotide-Directed,Mutagenesis, Site-Specific,Oligonucleotide-Directed Mutagenesis,Site-Directed Mutagenesis,Site-Specific Mutagenesis,Mutageneses, Oligonucleotide-Directed,Mutageneses, Site-Directed,Mutageneses, Site-Specific,Mutagenesis, Oligonucleotide Directed,Mutagenesis, Site Directed,Mutagenesis, Site Specific,Oligonucleotide Directed Mutagenesis,Oligonucleotide-Directed Mutageneses,Site Directed Mutagenesis,Site Specific Mutagenesis,Site-Directed Mutageneses,Site-Specific Mutageneses

Related Publications

Zheng Wang, and Junli Zhang, and Fan Li, and Xiaolin Ji, and Lingjie Liao, and Liying Ma, and Hui Xing, and Yi Feng, and Dan Li, and Yiming Shao
November 2011, Antiviral research,
Zheng Wang, and Junli Zhang, and Fan Li, and Xiaolin Ji, and Lingjie Liao, and Liying Ma, and Hui Xing, and Yi Feng, and Dan Li, and Yiming Shao
May 2012, Bing du xue bao = Chinese journal of virology,
Zheng Wang, and Junli Zhang, and Fan Li, and Xiaolin Ji, and Lingjie Liao, and Liying Ma, and Hui Xing, and Yi Feng, and Dan Li, and Yiming Shao
August 2008, Proceedings of the National Academy of Sciences of the United States of America,
Zheng Wang, and Junli Zhang, and Fan Li, and Xiaolin Ji, and Lingjie Liao, and Liying Ma, and Hui Xing, and Yi Feng, and Dan Li, and Yiming Shao
January 2006, Current pharmaceutical design,
Zheng Wang, and Junli Zhang, and Fan Li, and Xiaolin Ji, and Lingjie Liao, and Liying Ma, and Hui Xing, and Yi Feng, and Dan Li, and Yiming Shao
December 2012, Cellular and molecular biology (Noisy-le-Grand, France),
Zheng Wang, and Junli Zhang, and Fan Li, and Xiaolin Ji, and Lingjie Liao, and Liying Ma, and Hui Xing, and Yi Feng, and Dan Li, and Yiming Shao
March 2007, Current opinion in HIV and AIDS,
Zheng Wang, and Junli Zhang, and Fan Li, and Xiaolin Ji, and Lingjie Liao, and Liying Ma, and Hui Xing, and Yi Feng, and Dan Li, and Yiming Shao
December 2007, PLoS medicine,
Zheng Wang, and Junli Zhang, and Fan Li, and Xiaolin Ji, and Lingjie Liao, and Liying Ma, and Hui Xing, and Yi Feng, and Dan Li, and Yiming Shao
January 2007, AIDS (London, England),
Zheng Wang, and Junli Zhang, and Fan Li, and Xiaolin Ji, and Lingjie Liao, and Liying Ma, and Hui Xing, and Yi Feng, and Dan Li, and Yiming Shao
March 1999, Journal of molecular biology,
Zheng Wang, and Junli Zhang, and Fan Li, and Xiaolin Ji, and Lingjie Liao, and Liying Ma, and Hui Xing, and Yi Feng, and Dan Li, and Yiming Shao
September 2004, AIDS (London, England),
Copied contents to your clipboard!